We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

COIN:NASDAQCoinbase Global, Inc. Analysis

Data as of 2026-08-25 - not real-time

$179.48

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Coinbase Global, Inc. trades at $179.48, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. The last 30 days have gained 14.0%. Relative strength is 61.7 — approaching overbought — and the MACD signal is bullish. The recent range runs from support at $139.11 up to resistance at $191.84.
Valuation screens as overvalued: a P/E of 62.1 sits above the sector average of 17.0. The average analyst target implies 9.5% above today's level. Revenue is contracting at 17.3% on a -16.3% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 75.6%, a beta of 2.83 and a maximum drawdown of 63.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on sell — conviction 5 out of 10.

Top Market Events

Leon Neal/Getty Images News Coinbase Global COIN on Monday said it has selected Chainlink as its official oracle...Coinbase Global Inc NASDAQ:COIN stock is moving higher Wednesday as the broader cryptocurrency market finds its footing.Coinbase COIN stock rallies after Abu Dhabi approves its tokenized securities hub, enabling regulated digital asset...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 197.89
  • MACD momentum is positive

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 62.1 versus sector average of 17.0
  • Trading below the 200-day average of 197.89

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • P/E of 62.1 versus sector average of 17.0
  • Negative profit margin of -16.3%
  • Analyst targets imply +9.5% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-17.30%
Profit Margin-16.34%
P/E Ratio62.1
ROE-7.85%
ROA1.12%
Debt/Equity50.98
P/B Ratio3.6
Op. Cash Flow$1.7B
Free Cash Flow$2.7B
Industry P/E17.0

Technical Analysis

TrendBearish
RSI61.7
Support$139.11
Resistance$191.84
MA 20$156.40
MA 50$158.89
MA 200$197.89
MACDBullish
VolumeIncreasing
Fear & Greed Index93.13

Valuation

Fair Value$136.60
Target Price$196.55
Upside/Downside9.51%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.83
Volatility75.61%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.